Literature DB >> 15455807

Heart attack patients with complications. Treat with valsartan, captopril, or both?

Anne Nguyen1, Sudheer Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15455807      PMCID： PMC2214645     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

1.  Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.

Authors:  Douglas L Mann; Anita Deswal
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

2.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

3.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

Authors:  Kenneth Dickstein; John Kjekshus
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

4.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors:  John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

5.  VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.

Authors:  Eric J Velazquez; Marc A Pfeffer; John V McMurray; Aldo P Maggioni; Jean Lucien Rouleau; Frans Van de Werf; Lars Kober; Harvey D White; Karl Swedberg; Jeffrey D Leimberger; Paul Gallo; Mary Ann Sellers; Susan Edwards; Marc Henis; Robert M Califf
Journal:  Eur J Heart Fail       Date:  2003-08       Impact factor: 15.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.